Part 2 of a 7 Part Series: Advancing Early Detection, Prevention, and Clinical Trial Diversity in Puerto Rico
Immunotherapy and targeted therapies have transformed the way patients are treated and allow more patients than ever before to survive stage IV diagnoses. Other key advancements in oncology being prioritized in Puerto Rico today include early detection and prevention efforts. However, a lack of education, access, and health insurance coverage often prevents community members from timely cancer screenings. The same factors contribute to a lack of diversity in clinical trials, as noted by Dr. Marcia Cruz-Correa. Both these important issues require a community-based approach, through building…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.